Scotia Capital’s iShares Biotechnology ETF IBB Stock Holding History

Scotia Capital’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.74M	Sell	10,307 -68	-0.7%	-$11.6K	0.01%	487
2025 Q4	$1.75M	Buy	10,375 +731	+8%	+$119K	0.01%	477
2025 Q3	$1.39M	Buy	9,644 +2,242	+30%	+$306K	0.01%	510
2025 Q2	$936K	Sell	7,402 -1,676	-18%	-$206K	﹤0.01%	540
2025 Q1	$1.16M	Sell	9,078 -285	-3%	-$38.6K	0.01%	486
2024 Q4	$1.24M	Sell	9,363 -1,196	-11%	-$168K	0.01%	486
2024 Q3	$1.54M	Sell	10,559 -159	-1%	-$23K	0.01%	429
2024 Q2	$1.47M	Sell	10,718 -5,943	-36%	-$793K	0.01%	428
2024 Q1	$2.29M	Buy	16,661 +6,027	+57%	+$823K	0.01%	358
2023 Q4	$1.44M	Sell	10,634 -768	-7%	-$93.7K	0.01%	403
2023 Q3	$1.39M	Sell	11,402 -190	-2%	-$24.2K	0.01%	393
2023 Q2	$1.47M	Sell	11,592 -987	-8%	-$128K	0.01%	386
2023 Q1	$1.62M	Sell	12,579 -1,909	-13%	-$250K	0.01%	375
2022 Q4	$1.9M	Sell	14,488 -5,678	-28%	-$734K	0.01%	353
2022 Q3	$2.36M	Sell	20,166 -24	-0.1%	-$2.98K	0.02%	320
2022 Q2	$2.38M	Sell	20,190 -15,826	-44%	-$1.88M	0.02%	340
2022 Q1	$4.69M	Buy	36,016 +9,703	+37%	+$1.26M	0.03%	268
2021 Q4	$4.02M	Buy	26,313 +2,038	+8%	+$316K	0.03%	293
2021 Q3	$3.92M	Buy	24,275 +1,783	+8%	+$300K	0.03%	276
2021 Q2	$3.68M	Buy	22,492 +1,468	+7%	+$226K	0.03%	289
2021 Q1	$3.17M	Sell	21,024 -6,925	-25%	-$1.1M	0.03%	297
2020 Q4	$4.23M	Sell	27,949 -3,821	-12%	-$546K	0.04%	233
2020 Q3	$4.3M	Buy	31,770 +14,403	+83%	+$1.95M	0.05%	206
2020 Q2	$2.38M	Buy	17,367 +4,700	+37%	+$599K	0.03%	237
2020 Q1	$1.36M	Buy	12,667 +4,859	+62%	+$559K	0.02%	291
2019 Q4	$942K	Sell	7,808 -2,983	-28%	-$333K	0.01%	400
2019 Q3	$1.07M	Buy	10,791 +751	+7%	+$78.6K	0.01%	377
2019 Q2	$1.1M	Sell	10,040 -35,518	-78%	-$3.78M	0.01%	382
2019 Q1	$5.09M	Sell	45,558 -23,388	-34%	-$2.57M	0.07%	164
2018 Q4	$6.65M	Sell	68,946 -2,090	-3%	-$222K	0.1%	131
2018 Q3	$8.66M	Sell	71,036 -5,334	-7%	-$628K	0.11%	120
2018 Q2	$8.08M	Sell	76,370 -60	-0.1%	-$6.42K	0.11%	120
2018 Q1	$8.16M	Sell	76,430 -2,241	-3%	-$248K	0.11%	120
2017 Q4	$8.4M	Sell	78,671 -2,443	-3%	-$261K	0.11%	119
2017 Q3	$9.02M	Sell	81,114 -3,423	-4%	-$366K	0.13%	113
2017 Q2	$8.74M	Sell	84,537 -21,225	-20%	-$2.09M	0.15%	103
2017 Q1	$10.4M	Buy	105,762 +1,806	+2%	+$173K	0.18%	90
2016 Q4	$9.21M	Sell	103,956 -5,259	-5%	-$479K	0.15%	110
2016 Q3	$10.5M	Buy	109,215 +65,370	+149%	+$6.22M	0.19%	91
2016 Q2	$3.77M	Buy	43,845 +35,358	+417%	+$3.17M	0.08%	175
2016 Q1	$738K	Buy	8,487 +2,151	+34%	+$192K	0.02%	405
2015 Q4	$715K	Hold	6,336	–	–	0.02%	481
2015 Q3	$642K	Sell	6,336 -25,935	-80%	-$3.11M	0.01%	492
2015 Q2	$3.87M	Buy	32,271 +2,754	+9%	+$330K	0.08%	179
2015 Q1	$3.38M	Buy	+29,517	New	+$3.26M	0.09%	154

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Scotia Capital's IBB Position: Q1 2026 in Review

Scotia Capital reduced its iShares Biotechnology ETF (IBB) stake by 0.66% in Q1 2026, selling an estimated $11.6K and leaving 10,307 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #487.

Scotia Capital first reported a position in IBB in Q1 2015 and has held it in 45 quarters since. The position peaked at $10.5M in Q3 2016. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Scotia Capital held 10,307 shares of iShares Biotechnology ETF worth $1.74M as of Q1 2026.
Scotia Capital sold 68 iShares Biotechnology ETF shares in Q1 2026, an estimated $11.6K.
iShares Biotechnology ETF made up 0.01% of Scotia Capital's portfolio in Q1 2026, its #487 holding.
Scotia Capital first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 45 quarters since.
Scotia Capital's iShares Biotechnology ETF position peaked at $10.5M in Q3 2016.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.